ENTRE NÉGOCIATIONS ET EXPÉRIMENTATIONS: LES MUSÉES D'ETHNOGRAPHIE ET LA DÉCOLONISATION: Entretien avec Yann Laville et Grégoire Mayor (MEN) et Boris Wastiau (MEG).

Autor: Allain Bonilla, Marie-laure¹ m.allainbonilla@unibas.ch, Siegenthaler, Fiona² fiona.siegenthaler@unibas.ch

Publikováno v: Tsantsa. 2019, Vol. 24, p67-77. 11p.

Bruits — Echos du patrimoine culturel immatériel. Musée d'ethnographie de Neuchâtel : exposition du 2 octobre 2010 au 15 octobre 2011 Marc-Olivier GONSETH Bernard Knodel Yann Laville Grégoire Mayor

Autor: Depaule, Jean-Charles

Publikováno v: Cahiers d'ethnomusicologie, 2012 Jan 01. 25, 255-258.

Externí odkaz: https://www.jstor.org/stable/23621619

La marque jeune Marc-Olivier Gonseth Yan Laville Grégoire Mayor

Autor: Dufour-Laperrière, Nicolas

Publikováno v: Anthropologica, 2010 Jan 01. 52(2), 405-406.

Externí odkaz: https://www.jstor.org/stable/29546051

La cuisine mode d'emploi (convivial) : Lorna Bornand, Grégoire Mayor, Druey 22-30 - Les cuisines des voisins, Lausanne, 2014 (Graphisme : Ludovic Gerber, ultra studio, Vevey)

Autor: Gavillet, Françoise

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f178cf628a2a9a0b4c992aec2e524cc

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

Autor: Daniel Goldenberger, Piet Bosshard, Heike Püschel, Bernd Eisele, Grégoire Mayor, Leander Grode, Grégory Johann Wirth, Andreas Wicki, Régine Audran, Richard Cathomas, Malte Rieken, Gerald P Parzmair, Cyrill A. Rentsch, François Spertini, Simona Berardi, Manish Gupta, Umesh Shaligram, Stefanie Hayoz, Hitt Sharma, Milica Enoiu, Sunil Gairola

Publikováno v: OncoImmunology, Vol 9, Iss 1 (2020)
OncoImmunology, Vol. 9, No 1 (2020) P. 1748981
Oncoimmunology
Rentsch, Cyrill A; Bosshard, Piet; Mayor, Grégoire; Rieken, Malte; Püschel, Heike; Wirth, Grégory; Cathomas, Richard; Parzmair, Gerald P; Grode, Leander; Eisele, Bernd; Sharma, Hitt; Gupta, Manish; Gairola, Sunil; Shaligram, Umesh; Goldenberger, Daniel; Spertini, François; Audran, Régine; Enoiu, Milica; Berardi, Simona; Hayoz, Stefanie; ... (2020). Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy. Oncoimmunology, 9(1), p. 1748981. Taylor & Francis 10.1080/2162402X.2020.1748981

Background: VPM1002BC is a modified mycobacterium Bacillus Calmette Guérin (BCG) for the treatment of non-muscle invasive bladder cancer (NMIBC). The genetic modifications are expected to result in better immunogenicity and less side effects. We rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3515d5b00a10cf12aa33311c3fe66245
https://doaj.org/article/435b8c0fec2b484c8e79c927de64db29